If a company builds its stock price on a foundation of faulty breakthrough products, manipulated safety data, or non-existent market demand, investors are the ones who suffer negative consequences. Securities fraud claims of misleading product information often involve materially false or deceptive statements knowingly made by a corporation about its primary revenue drivers.

The class action attorneys at Silver Law Group have the resources, knowledge, and experience to expose these types of securities fraud. If a company’s fraudulent product claims caused you significant losses, our team of nationally recognized lawyers can help you hold the business’s executives and board members accountable for their lack of transparency.

What Misleading Product Information Constitutes Securities Fraud?

In the modern marketplace, a company’s stock price is often inextricably tied to the perceived success, safety, or disruptive nature of its core products. Securities fraud frequently involves companies making material, deceptive statements or omitting crucial details about products to artificially boost their valuations.

This applies to both public and private firms artificially increasing stock prices or private funding rounds through fraudulent, misleading, or exaggerated claims. At Silver Law Group, we have identified several high-impact mechanisms of product-based deception, including:

  • Clinical trial and safety manipulation: Biotech and pharmaceutical firms that selectively choose data to hide dangerous side effects or exaggerate the efficacy of a drug to ensure FDA approval or investor buy-in
  • Technological vaporware: Tech companies that claim to have a functional, revolutionary proprietary code or hardware that, in reality, has undisclosed glitches or unfixable defects
  • Falsified market demand: Corporations that misrepresent pre-order numbers or engage in channel-stuffing to create a fictitious narrative of product success before a quarterly earnings report
  • Environmental and regulatory concealment: Manufacturing entities that hide product defects, such as faulty components or toxic emissions

If a corrective disclosure finally reveals the truth to the market, the resulting price collapse can destroy millions of dollars of investor capital, leaving shareholders with a devalued portfolio and the emotional impact of betrayed fiduciary trust. At Silver Law Group, we implement tailored litigation strategies designed to hold individuals and entities accountable for securities fraud related to misleading product information.

Our attorneys regularly pursue litigation against liable parties beyond the corporation itself, including the officers, directors, and auditors who certified misleading reports as well as any banks or other institutions that supported the fraud. We spearhead both securities class actions and individual litigation, and can advise you on the forum that offers the highest probability of fair financial recovery.

Legal Requirements To Pursue A Securities Fraud Claim Of Misleading Product Information

To hold a corporation and its executives accountable for securities fraud related to misleading product details, a plaintiff in a class action or lawsuit must establish several critical elements, including:

  • Material misrepresentation or omission: Prove the company made a statement that was objectively false or omitted a fact that a reasonable investor would consider important to their investment decision
  • Scienter (intent to deceive): Demonstrate that the defendant(s) acted with a state of mind to deceive, manipulate, or defraud—or, at the very least, acted with extreme recklessness regarding the truth of their product claims
  • Loss causation: Show that a direct causal connection exists between the concealment of the product defect and the financial loss you suffered after disclosure of the truth
  • Reliance: Prove that you and other investors purchased the securities based on the integrity of the price, which the misleading information artificially increased

Our team of lawyers, forensic accountants, and support staff can leverage expert witnesses, internal document discovery, and other vital evidence to expose intentional concealment and help you recover the lost funds. At Silver Law Group, we work on a contingency fee basis, meaning you incur no upfront costs for our services. Our fees are a percentage of the final settlement or verdict, which the court must approve.

Call Our Attorneys To File A Misleading Product Information Securities Fraud Claim

If a corporation chooses exaggerated promotional publicity over honesty, it violates the fundamental fiduciary duty it owes to its shareholders. Silver Law Group has a notable history of recovering millions for investors by aggressively litigating complex securities class actions.

We manage consequential securities fraud claims of misleading product information on a contingency fee basis. If you believe a company’s intentional misrepresentation of its products resulted in your investment losses, don’t wait and give the evidence time to disappear. Contact us today for a free, confidential consultation.